C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 263/32 (2006.01) A61K 31/00 (2006.01) A61K 31/42 (2006.01) A61K 31/427 (2006.01) A61K 31/433 (2006.01) A61K 31/4439 (2006.01) A61K 31/454 (2006.01) A61K 31/4709 (2006.01) A61K 31/4725 (2006.01) A61K 31/496 (2006.01) A61K 31/506 (2006.01) A61K 31/5377 (2006.01) A61K 38/21 (2006.01) A61K 45/06 (2006.01) A61P 9/10 (2006.01) A61P 11/06 (2006.01) A61P 31/00 (2006.01) A61P 33/00 (2006.01) A61P 35/00 (2006.01) C07D 249/08 (2006.01) C07D 263/48 (2006.01) C07D 413/12 (2006.01) C07D 417/12 (2006.01)
Patent
CA 2337588
Disclosed are compounds of the general formula Image wherein R1 represents heterocyclyl; R2 represents hydrogen, unsubstituted lower alkyl, lower alkoxy, halo, hydroxy or cyano; R3 represents hydrogen, unsubstituted lower alkyl, lower alkoxy, halo, or cyano; R4 represents hydrogen, lower alkyl, lower cycloalkyl, aryl, or heterocyclyl; R5 represents hydrogen, unsubstituted lower alkyl, lower alkoxy, halo, or cyano; R6 represents hydrogen, unsubstituted lower alkyl, lower alkoxy, halo, or cyano; R7 represents hydrogen, or unsubstituted lower alkyl; R8 represents hydrogen, or unsubstituted lower alkyl; or R4 and R8 together with the nitrogen atom to which they are attached represent heterocyclyl; and pharmaceutically acceptable salts thereof. The disclosed oxamide derivatives are inhibitors of the enzyme inosine monophosphate dehydrogenase (IMPDH). They can be used as medicaments, especially for treating immune mediated conditions or diseases, viral diseases, bacterial diseases, parasitic diseases, inflammation, inflammatory diseases, hyperproliferative vascular diseases, tumours, and cancer. They can be used alone, or in combination with other therapeutically active agents, for example, an immunosuppressant, a chemotherapeutic agent, an anti-viral agent, an antibiotic, an anti- parasitic agent, an anti-inflammatory agent, an anti-fungal agent and/or an anti-vascular hyperproliferation agent.
Broadhurst Michael John
Hill Christopher Huw
Hurst David Nigel
Jones Philip Stephen
Kay Paul Brittain
Borden Ladner Gervais Llp
F. Hoffmann-La Roche Ag
LandOfFree
Oxamides as impdh inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxamides as impdh inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxamides as impdh inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1840713